Insmed - Stock Price History | INSM

Historical daily share price chart and data for Insmed since 2020 adjusted for splits. The latest closing stock price for Insmed as of July 02, 2020 is 29.57.
  • The all-time high Insmed stock closing price was 195.00 on August 30, 2000.
  • The Insmed 52-week high stock price is 34.94, which is 18.2% above the current share price.
  • The Insmed 52-week low stock price is 12.09, which is 59.1% below the current share price.
  • The average Insmed stock price for the last 52 weeks is 21.75.
Insmed Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 23.3077 13.9700 32.1900 13.9100 23.8800 82.01%
2018 22.6387 32.4600 32.9900 11.6000 13.1200 -57.92%
2017 20.2914 13.0800 31.7800 11.6100 31.1800 135.68%
2016 12.7351 17.2400 17.2400 9.0500 13.2300 -27.11%
2015 20.7534 15.9600 27.5400 14.1600 18.1500 17.32%
2014 15.7364 17.1400 21.5400 11.6500 15.4700 -9.00%
2013 11.2478 6.9600 17.3300 5.7200 17.0000 154.11%
2012 4.3827 3.1500 8.0000 2.7000 6.6900 119.34%
2011 6.4065 6.4000 13.1500 2.6400 3.0500 -51.65%
2010 8.1390 7.7000 12.5000 5.7000 6.3080 -18.08%
2009 9.7689 4.9000 24.7000 4.1500 7.7000 64.71%
2008 6.0865 8.3000 9.1000 3.4990 4.6750 -43.33%
2007 8.8034 9.0000 15.6000 5.7700 8.2500 -6.25%
2006 16.1210 21.3000 31.2000 8.5000 8.8000 -55.33%
2005 12.6992 23.0000 23.0000 8.2000 19.7000 -10.41%
2004 23.1546 30.3000 40.9000 10.1000 21.9900 -25.96%
2003 20.0198 4.8000 34.2000 4.1000 29.7000 561.47%
2002 17.7447 39.4000 39.4000 3.5000 4.4900 -88.25%
2001 45.0069 37.5000 89.9000 24.7000 38.2000 10.12%
2000 120.0576 164.8000 195.0000 26.8800 34.6900 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.988B $0.136B
Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections. Insmed is also focused on the development of INS1009, the company's inhaled treprostinil prodrug for the treatment of pulmonary arterial hypertension (PAH), a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $151.909B 16.73
Gilead Sciences (GILD) United States $95.771B 12.41
CSL (CSLLY) Australia $92.036B 0.00
Vertex Pharmaceuticals (VRTX) United States $75.476B 51.89
Regeneron Pharmaceuticals (REGN) United States $68.481B 26.40
Illumina (ILMN) United States $54.846B 56.36
Biogen (BIIB) United States $43.264B 7.41
Seattle Genetics (SGEN) United States $29.259B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.799B 10.65
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $23.288B 0.00
Incyte (INCY) United States $23.144B 0.00
BioMarin Pharmaceutical (BMRN) United States $22.927B 207.84
Genmab (GMAB) Denmark $21.830B 17.98
Moderna (MRNA) United States $21.743B 0.00
Genmab (GNMSF) Denmark $20.499B 60.86
Alnylam Pharmaceuticals (ALNY) United States $17.289B 0.00
BeiGene (BGNE) Cayman Islands $15.148B 0.00
BioNTech SE (BNTX) Germany $14.316B 0.00
Galapagos (GLPG) Belgium $13.070B 38.45
Exact Sciences (EXAS) United States $12.992B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
Sarepta Therapeutics (SRPT) United States $12.693B 0.00
ARGENX SE-ADR (ARGX) Netherlands $10.752B 0.00
Horizon Therapeutics Public (HZNP) Ireland $10.539B 25.93
Bio-Techne Corp (TECH) United States $10.289B 67.97
QIAGEN (QGEN) Netherlands $9.682B 28.15
Immunomedics (IMMU) United States $8.668B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.044B 0.00
Guardant Health (GH) United States $7.902B 0.00
Ascendis Pharma (ASND) Denmark $7.246B 0.00
Exelixis (EXEL) United States $7.200B 25.25
Repligen (RGEN) United States $6.625B 116.19
Adaptive Biotechnologies (ADPT) United States $6.026B 0.00
Acceleron Pharma (XLRN) United States $5.455B 0.00
Reata Pharmaceuticals (RETA) United States $5.246B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.133B 0.00
Mirati Therapeutics (MRTX) United States $5.106B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.938B 106.27
Vir Biotechnology (VIR) United States $4.754B 0.00
Novavax (NVAX) United States $4.732B 0.00
Zai Lab (ZLAB) China $4.712B 0.00
Emergent Biosolutions (EBS) United States $4.408B 28.89
MyoKardia (MYOK) United States $4.393B 0.00
MorphoSys AG (MOR) Germany $4.303B 33.38
Blueprint Medicines (BPMC) United States $4.289B 0.00
Global Blood Therapeutics (GBT) United States $4.134B 0.00
China Biologic Products (CBPO) China $4.101B 22.80
Amicus Therapeutics (FOLD) United States $4.007B 0.00
Halozyme Therapeutics (HALO) United States $3.872B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.798B 0.00
NeoGenomics (NEO) United States $3.569B 260.62
Inovio Pharmaceuticals (INO) United States $3.391B 0.00
Bluebird Bio (BLUE) United States $3.311B 0.00
Arena Pharmaceuticals (ARNA) United States $3.176B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.168B 0.00
Alkermes (ALKS) Ireland $3.110B 61.22
Fate Therapeutics (FATE) United States $2.813B 0.00
Denali Therapeutics (DNLI) United States $2.688B 0.00
Amarin (AMRN) Ireland $2.668B 0.00
Viela Bio (VIE) United States $2.178B 0.00
UniQure (QURE) Netherlands $2.018B 0.00
PHARMA MAR SA (PHMMF) Spain $2.014B 0.00
Eidos Therapeutics (EIDX) United States $1.899B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.897B 0.00
Twist Bioscience (TWST) United States $1.892B 0.00
Alector (ALEC) United States $1.882B 0.00
Principia Biopharma (PRNB) United States $1.850B 0.00
Ligand Pharmaceuticals (LGND) United States $1.792B 69.78
Editas Medicine (EDIT) United States $1.686B 0.00
I-Mab (IMAB) China $1.673B 0.00
Adverum Biotechnologies (ADVM) United States $1.672B 0.00
Zymeworks (ZYME) Canada $1.639B 0.00
Intra-Cellular Therapies (ITCI) United States $1.609B 0.00
Epizyme (EPZM) United States $1.599B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.551B 0.00
Beam Therapeutics (BEAM) United States $1.486B 0.00
Mersana Therapeutics (MRSN) United States $1.480B 0.00
Cytokineticsorporated (CYTK) United States $1.477B 0.00
Sorrento Therapeutics (SRNE) United States $1.436B 0.00
Revance Therapeutics (RVNC) United States $1.434B 0.00
Akcea Therapeutics (AKCA) United States $1.428B 0.00
Zealand Pharma (ZEAL) Denmark $1.425B 0.00
REGENXBIO (RGNX) United States $1.419B 0.00
Mesoblast (MESO) Australia $1.403B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
Sangamo Therapeutics (SGMO) United States $1.357B 0.00
Arvinas (ARVN) United States $1.326B 0.00
NGM Biopharmaceuticals (NGM) United States $1.308B 0.00
Coherus BioSciences (CHRS) United States $1.298B 9.06
Adaptimmune Therapeutics (ADAP) United Kingdom $1.274B 0.00
NantKwest (NK) United States $1.181B 0.00
Intellia Therapeutics (NTLA) United States $1.146B 0.00
Athenex (ATNX) United States $1.120B 0.00
Arcus Biosciences (RCUS) United States $1.107B 0.00
Compugen (CGEN) Israel $1.054B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.969B 0.00
Alcobra (ARCT) United States $0.926B 0.00
Retrophin (RTRX) United States $0.897B 0.00
Heska (HSKA) United States $0.865B 0.00
Myriad Genetics (MYGN) United States $0.863B 44.54
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Intrexon (PGEN) United States $0.830B 0.00
Pharming Group (PHGUF) Netherlands $0.826B 22.00
Cara Therapeutics (CARA) United States $0.820B 0.00
Dynavax Technologies (DVAX) United States $0.799B 0.00
Morphic Holding (MORF) United States $0.796B 0.00
Cellectis S.A (CLLS) France $0.792B 0.00
Kadmon Holdings (KDMN) United States $0.755B 0.00
Bellus Health (BLU) Canada $0.726B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.713B 0.00
Codexis (CDXS) United States $0.712B 0.00
Frequency Therapeutics (FREQ) United States $0.702B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.694B 0.00
Vericel (VCEL) United States $0.682B 125.92
Agenus (AGEN) United States $0.673B 0.00
Castle Biosciences (CSTL) United States $0.662B 0.00
VBI Vaccines (VBIV) United States $0.662B 0.00
Cue Biopharma (CUE) United States $0.651B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.646B 5.54
Sinovac Biotech (SVA) China $0.640B 20.87
AnaptysBio (ANAB) United States $0.615B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.598B 0.00
NextCure (NXTC) United States $0.583B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.577B 0.00
Kala Pharmaceuticals (KALA) United States $0.576B 0.00
Syros Pharmaceuticals (SYRS) United States $0.555B 0.00
MiMedx (MDXG) United States $0.552B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.545B 0.00
Anika Therapeutics (ANIK) United States $0.545B 17.52
Aquinox Pharmaceuticals (NLTX) United States $0.537B 0.00
UROGEN PHARMA (URGN) United States $0.530B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.526B 0.00
Scholar Rock Holding (SRRK) United States $0.526B 0.00
Athersys (ATHX) United States $0.525B 0.00
Clovis Oncology (CLVS) United States $0.508B 0.00
DBV Technologies S.A (DBVT) France $0.491B 0.00
Protagonist Therapeutics (PTGX) United States $0.487B 0.00
AC Immune SA (ACIU) Switzerland $0.477B 0.00
MeiraGTx Holdings (MGTX) United States $0.460B 0.00
Merus (MRUS) Netherlands $0.459B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.448B 0.00
BioDelivery Sciences (BDSI) United States $0.445B 23.37
Geron (GERN) United States $0.441B 0.00
Prothena (PRTA) Ireland $0.438B 0.00
Precision BioSciences (DTIL) United States $0.437B 0.00
Puma Biotechnology (PBYI) United States $0.415B 0.00
Avid Bioservices (CDMO) United States $0.407B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.404B 0.00
Kamada (KMDA) Israel $0.393B 16.35
Prometic Life Sciences (LMNL) Canada $0.392B 0.00
Albireo Pharma (ALBO) United States $0.389B 0.00
CytomX Therapeutics (CTMX) United States $0.386B 0.00
MannKind (MNKD) United States $0.382B 0.00
ANI Pharmaceuticals (ANIP) United States $0.374B 7.41
Seres Therapeutics (MCRB) United States $0.362B 0.00
WAVE Life Sciences (WVE) Singapore $0.354B 0.00
Affimed (AFMD) Germany $0.348B 0.00
PDL BioPharma (PDLI) United States $0.339B 291.00
OSMOTICA PHARM (OSMT) United States $0.333B 0.00
Cellular Biomedicine (CBMG) United States $0.323B 0.00
Starpharma Holdings (SPHRY) Australia $0.310B 0.00
Menlo Therapeutics (MNLO) United States $0.283B 0.00
Celldex Therapeutics (CLDX) United States $0.280B 0.00
ChromaDex (CDXC) United States $0.279B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.277B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.276B 0.00
Spero Therapeutics (SPRO) United States $0.275B 0.00
Verastem (VSTM) United States $0.271B 0.00
IVERIC Bio (ISEE) United States $0.262B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.261B 0.00
Northwest Biotherapeutics (NWBO) United States $0.251B 0.00
Dyadic (DYAI) United States $0.250B 0.00
ADMA Biologics Inc (ADMA) United States $0.250B 0.00
Gritstone Oncology (GRTS) United States $0.245B 0.00
Selecta Biosciences (SELB) United States $0.240B 0.00
Abeona Therapeutics (ABEO) United States $0.239B 0.00
HOOKIPA Pharma (HOOK) United States $0.235B 0.00
Aptinyx (APTX) United States $0.228B 0.00
Five Prime Therapeutics (FPRX) United States $0.224B 0.00
Pluristem Therapeutics (PSTI) Israel $0.222B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.222B 0.00
Fortress Biotech (FBIO) United States $0.222B 0.00
Liquidia Technologies (LQDA) United States $0.221B 0.00
XOMA (XOMA) United States $0.221B 0.00
Exicure (XCUR) United States $0.216B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.208B 3.13
GENFIT S.A (GNFT) France $0.206B 0.00
Aduro Biotech (ADRO) United States $0.202B 0.00
Strongbridge Biopharma (SBBP) United States $0.200B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
ARAVIVE, INC (ARAV) United States $0.186B 0.00
Sutro Biopharma (STRO) United States $0.173B 0.00
Applied Genetic Technologies (AGTC) United States $0.166B 0.00
Aytu Bioscience (AYTU) United States $0.165B 0.00
Trevena (TRVN) United States $0.164B 0.00
Kindred Biosciences (KIN) United States $0.164B 0.00
Cyclerion Therapeutics (CYCN) United States $0.163B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.160B 0.00
TELA Bio (TELA) United States $0.156B 0.00
VTv Therapeutics (VTVT) United States $0.154B 0.00
Cerecor (CERC) United States $0.153B 0.00
Theratechnologies (THTX) Canada $0.152B 0.00
Cidara Therapeutics (CDTX) United States $0.151B 0.00
Biofrontera AG (BFRA) Germany $0.148B 0.00
Celyad SA (CYAD) Belgium $0.142B 0.00
Celsion (CLSN) United States $0.136B 0.00
Lumos Pharma (LUMO) United States $0.134B 0.00
Orgenesis (ORGS) United States $0.130B 0.00
Arbutus Biopharma (ABUS) United States $0.130B 0.00
PHASEBIO PHARMA (PHAS) United States $0.126B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.120B 0.00
AIT Therapeutics (XAIR) United States $0.119B 0.00
Oncobiologics (OTLK) United States $0.118B 0.00
Eton Pharmaceuticals (ETON) United States $0.115B 0.00
Enzo Biochem (ENZ) United States $0.111B 0.00
Checkpoint Therapeutics (CKPT) United States $0.110B 0.00
DiaMedica Therapeutics (DMAC) United States $0.101B 0.00
AquaBounty Technologies (AQB) United States $0.099B 0.00
Windtree Therapeutics (WINT) United States $0.096B 0.00
Antibe Therapeutics (ATBPF) Canada $0.092B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.091B 0.00
Clearside Biomedical (CLSD) United States $0.087B 0.00
Cardiff Oncology (CRDF) United States $0.083B 0.00
Emmaus Life Sciences (EMMA) United States $0.082B 0.00
Organovo Holdings (ONVO) United States $0.081B 0.00
Cocrystal Pharma (COCP) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.079B 0.00
SESEN BIO, INC (SESN) United States $0.078B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.073B 0.00
Proteostasis Therapeutics (PTI) United States $0.071B 0.00
Happiness Biotech Group (HAPP) China $0.070B 0.00
Catalyst Biosciences (CBIO) United States $0.070B 0.00
AnPac Bio-Medical Science (ANPC) China $0.069B 0.00
Synlogic (SYBX) United States $0.064B 0.00
Stealth BioTherapeutics (MITO) United States $0.064B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.063B 0.00
Idera Pharmaceuticals (IDRA) United States $0.062B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
CollPlant Holdings (CLGN) Israel $0.057B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.056B 0.00
Signal Genetics (MGEN) United States $0.056B 0.00
Vaccinex (VCNX) United States $0.055B 0.00
Soligenix (SNGX) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.046B 0.00
Edesa Biotech (EDSA) Canada $0.044B 0.00
Pulmatrix (PULM) United States $0.044B 0.00
Curis (CRIS) United States $0.043B 0.00
Prima BioMed (IMMP) Australia $0.041B 0.00
Bionano Genomics (BNGO) United States $0.041B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Acorda Therapeutics (ACOR) United States $0.035B 0.00
Cesca Therapeutics (THMO) United States $0.035B 0.00
Advaxis (ADXS) United States $0.034B 0.00
Chanticleer Holdings (SONN) United States $0.033B 0.00
OvaScience (MLND) United States $0.033B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.032B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Alimera Sciences (ALIM) United States $0.029B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Spherix (AIKI) United States $0.028B 0.00
IMMURON (IMRN) Australia $0.026B 0.00
Evogene (EVGN) Israel $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
Novogen (KZIA) Australia $0.025B 0.00
FORTE BIOSCIENC (FBRX) United States $0.024B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
Genetic Technologies (GENE) Australia $0.021B 0.00
Entera Bio (ENTX) Israel $0.020B 0.00
MYOS RENS Technology (MYOS) United States $0.019B 0.00
BioCardia (BCDA) United States $0.016B 0.00
VIVUS (VVUS) United States $0.014B 0.00
Unum Therapeutics (UMRX) United States $0.014B 0.00
Neuralstem (SNCA) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
AEterna Zentaris (AEZS) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00